No Detail Found!

Efficacy and Safety of Dexmedetomidine as An Intrathecal Agent: a Dose Finding Clinical Study.

Author(s)
Arvinder Pal Singh Sri Guru Ram Das Institute of Medical Sciences & Research, Amritsar, Punjab, India
Sunil Chawla Sri Guru Ram Das Institute of Medical Sciences & Research, Amritsar, Punjab, India
Sukhminder Jit Singh Bajwa Department of Anesthesiology and Intensive Care, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab, India
Menaal Khanna Department of Anesthesiology and Intensive Care, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab, India
Abstract
Background and Objectives: Dexmedetomidine is increasingly being used in regional anesthesia as an adjuvant but there is no consensus on exact minimal and safe dose when used intrathecally. The present study was conducted to evaluate the efficacy of three different doses of dexmedetomidine when given intrathecally as an adjuvant to bupivacaine in patients undergoing lower abdominal surgery. Methodology: After taking ethical committee approval, and obtaining patients consent, 60 American Society of Anesthesiologist (ASA) physical status I and II patients in the age group of 25-60 years undergoing lower abdominal surgeries were divided randomly into three groups in this randomized double blind study. An intrathecal dose of 2.5 ml of 0.5% hyperbaric bupivacaine was administered to all patients supplemented with dexmedetomidine. In Group A 5 µg, Group B 7.5 µg and in Group C 10 µg of dexmedetomidine was administered with a volume of 3ml of study drug in each group. The onset time, time to peak sensory level, motor blockade, sedation, duration of motor block, analgesia and any adverse effects were noted. At the end of the study, data were compiled and analyzed with appropriate statistical tests. Results: Demographic profile was comparable in all the three groups. The time to onset of sensory block in Group C (1.55 ± 0.510 min) was significantly lower than Group A (2.15 ± 0.745 min) and Group B (2.20 ± 0.410 min). Sensory regression by two segments was significantly higher in Group C (220.65 ± 25.86 min) as compared to Group A (104.7 ± 25.5min) and Group B (145.10 ± 24.54 min). (p < 0.05) The duration of motor block was shortest in Group A (243.8 ± 22.0 min) as compared to Group B (305.4 ± 35.8 min) and Group C (387.0 ± 39.4 min). The visual analogue scale score for pain was lesser in Group C as compared to the other two groups. Conclusion: Optimal dose of dexmedetomidine is difficult to define especially with prolonged duration of sensory and motor blockade in a dose dependent manner with minimal increase in side effects with higher doses. However, we conclude that 7.5 µg seems to be just optimal intrathecal dose of dexmedetomidine and can be used safely and effectively in lower abdominal surgeries.
Publication Details
Page(s) 13-18
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 21, Issue: 1, Year: 2017

Request the full text from PASTIC

References
2014., 10 114 -7
Anesthesiology.Clinics, 1989., 27 51 -55
BajwaSJ,BajwaSK,KaurJ,SinghA,BakshiG,SinghK,GuptaR,VermaR,BograJ,KohliM,RamanR,KushwahaJK, .A comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to bupivacaine,2010 JanJun;4 9 -14
J Anaesthesiol Clin Pharmacol,AroraV,KaurJ,SinghA,ParmarSS, 2011.Comparative evaluation of dexmedetomidine and fentanyl for epidural analgesia in lower limb orthopedic surgeries,Saudi J Anaesth 10 87264 -354X
Dexmedetomidine, 2013.An adjuvant making large inroads into clinical practice,Ann Med Health Sci Res 3 475 -83
KamibayashiT,MazeM., .Clinical uses of α2- adrenergic agonists, -
Anesthesiology, ., 9 1345 -9
EidHA,ShafieM,Yousef H. Dose -, 2011.Related prolongation of Hyperbaric Bupivacaine Spinal Anaesthesia By Dexmedetomidine,Ain Shams J Anesthesiol 4 83 -95
BuvanendranA,KrroinJS, 2007.Useful adjuvants for post-operative pain management,Best Pract Res Clin Anaesthesiol 21 31 -49
BernardsCM,BarashPG,CullinBF,StoeltingRK, .Epidural and spinal anaesthesia,Clinical Anaesthesia. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2009 928 -37
BajwaSJ,BajwaSK,KaurJ,SinghA,BakshiG,SinghK, .Admixture of clonidine and fentanyl to ropivacaine in epidural anesthesia for lower abdominal surgery,2010 JamJun;4 10 69299 -1162
HallJE,JurichTD,BarneyJA,ArianSR,EbertTJ, 2009.Sedative amnestic and analgesic properties of small dose of dexmedetomidine infusions,Anesth Analg 90 699 -705
BajwaSJ,BajwaSK,KaurJ,SinghG,AroraV,GuptaS, 2011.Dexmedetomidine and clonidine in epidural anaesthesia: A comparative evaluation,Indian J Anaesth 10 79883 -5049
GabrialJS,GordinV, 2001.Alpha-2 agonists in regional anaesthesia and analgesia,Curr Opin Anaesthesiol 14 751 -3
BajwaSJ,GuptaS,KaurJ,SinghA,ParmarS., 2012.Reduction in the incidence of shivering with perioperative dexmedetomidine: A randomized prospective study,J Anaesthesiol Clin Pharmacol 10 92452 -9185
Eisenach JamesC,De KockM,KlimschaW.,).Anesthesiology, .Alpha sub 2-adrenergic agonist for regional anesthesia. A clinical review of clonidine (1984-1995, 85 655 -74
Al-MustafaMM,Abu-HalawehSA,AloweidiAS,MurshidiMM,AmmariBA,AwwadZM, 2009.Effect of dexmedetomidine added to spinal bupivacaine for urological procedures,Saudi Med 30 365 -70
SaadawyI,BokerA,EishahawyMA,AlmaazrooaA,MelibaryS,AbdellatifAA, 01818.Effect of dexmedetomidine on the characteristics of bupivacaine in a caudal block in pediatrics,Acta Anaesthesiol Scand 10 6576 -6
ShahA,PatelI,GandhiR, 2013.Haemodynamic effect of intrathecal dexmedetomidine added to ropivacaine intraoperatively and for postoperative analgesia,Int J Bas Clin Pharmacol 2 26 -9
SunilBV,SahanaKS,JajeePR, 2013.Dexmedetomidine as an adjuvant with hyperbaric bupivacaine for spinal anaesthesia: a double blind controlled study”,J Evolution med dent Sci 2 7604 -11
GrewalA, 2011.New avenues,J Anaesthesiol Clin Pharmacol 27 297 -302
IshiiH,KohnoT,YamakuraT,IkomaM,Baba H, 2008.Action of dexmedetomidine on the substantia gelatinosa neurons of the rat spinal cord,Euro J Neurosci 06260 9568 -90
EisenachJC,ShaferSL,BucklinBA,JacksonC, .Kallio A. Pharmacokinetics and pharmacodynamics of intraspinal dexmedetomidine in sheep,Anesthesiology 80 134 -59
0

Citations

0

Downloads

83

Views